SERTAD2 Antikörper (AA 111-210) (Cy5)
Kurzübersicht für SERTAD2 Antikörper (AA 111-210) (Cy5) (ABIN914689)
Target
Alle SERTAD2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 111-210
-
Kreuzreaktivität
- Human
-
Homologie
- Mouse,Rat,Dog,Chicken
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human SERTAD2
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- SERTAD2 (SERTA Domain Containing 2 (SERTAD2))
-
Andere Bezeichnung
- SERTAD2
-
Hintergrund
-
Synonyms: Sei 2, Sei-2, Sei2, SERTA domain containing 2, SERTA domain-containing protein 2, Transcriptional regulator interacting with the PHD bromodomain 2, Transcriptional regulator interacting with the PHD-bromodomain 2, Transcriptional regulator interacting with the PHS-bromodomain 2, TRIP Br2, TRIP-Br2, KIAA0127, MGC126688, MGC126690, SRTD2_HUMAN.
Background: SERTA domain containing 2 (SERTAD2) acts at E2F-responsive promoters to integrate signals provided by PHD- and/or bromodomain-containing transcription factors.
-
Gen-ID
- 9792
Target
-